What is the hereditary pattern of Hemophilia A?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hereditary Pattern of Hemophilia A

Hemophilia A is an X-linked recessive congenital bleeding disorder that primarily affects males due to their single X chromosome, while females typically serve as carriers of the disease 1.

Genetic Basis and Inheritance

  • Hemophilia A results from deficiency of functional coagulation factor VIII (FVIII), which is encoded by the F8 gene located on the X chromosome 1, 2
  • Most individuals with hemophilia A have a pathogenic variant in the F8 gene 1
  • As an X-linked recessive disorder, males who inherit the mutated F8 gene will develop hemophilia A, while females with one mutated copy typically become carriers 2
  • The estimated prevalence of hemophilia A at birth is 24.6 cases per 100,000 males, accounting for approximately 80-85% of all hemophilia cases 1
  • For every 100 males with hemophilia, there are approximately 277 potential carriers 2

Disease Manifestation in Males

  • Males with hemophilia A express the full disease phenotype due to having only one X chromosome 3
  • Severity is classified based on factor VIII activity levels 4:
    • Severe: <1% of normal factor VIII activity
    • Moderate: 1-5% of normal factor VIII activity
    • Mild: >5% to <40% of normal factor VIII activity

Female Carriers

  • Females who inherit one mutated F8 gene typically become asymptomatic carriers due to the presence of a second, normal X chromosome 3, 2
  • Female carriers usually have factor VIII levels around 50% of normal, which is generally sufficient to prevent bleeding symptoms 3
  • Carrier detection has evolved from phenotypic studies based on coagulation tests to highly precise genetic analysis using next-generation sequencing 5
  • Single nucleotide polymorphism (SNP) and microsatellite markers can be used for successful identification of carriers in affected families 6

Rare Cases of Symptomatic Female Carriers

  • In rare instances, female carriers may manifest symptoms of hemophilia A due to skewed X-chromosome inactivation (lionization) 3, 7, 5
  • Skewed X-chromosome inactivation occurs when more normal X chromosomes are converted to Barr bodies, leaving more abnormal chromosomes active in body cells 3
  • The severity of manifestations in symptomatic female carriers is directly proportional to the level of clotting factor in the blood 3
  • Symptomatic female carriers may require the same treatment approaches as affected males 3

Genetic Testing and Counseling

  • Molecular characterization of hemophilia A may involve:
    • Detection of intron 22 inversion (a common mutation in severe hemophilia A) 7
    • Multiplex ligation-dependent probe amplification to detect large deletions 7
    • Analysis of X-chromosome inactivation status 7, 5
  • Genetic counseling is essential for families affected by hemophilia A, especially for carrier females planning pregnancies 5
  • Prenatal diagnosis options have evolved from examination of FVIII levels in fetal blood samples to genetic analysis of fetal DNA from chorionic villus sampling 5
  • In some countries, in vitro fertilization combined with preimplantation genetic diagnosis has become the procedure of choice for carriers wishing to prevent transmission of hemophilia A 5

Clinical Implications

  • Understanding the X-linked inheritance pattern is crucial for:
    • Accurate genetic counseling of affected families 5
    • Identifying at-risk female carriers 5, 6
    • Prenatal diagnosis and family planning 5
    • Appropriate clinical management of both affected males and symptomatic female carriers 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

General concepts on hemophilia A and on women carrying the disease.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2020

Guideline

Factor VIII Measurement and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Molecular characterization of female hemophilia A by multiplex ligation-dependent probe amplification analysis and X-chromosome inactivation study.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.